Isis Pharmaceuticals, Inc. News, Isis Pharmaceuticals, Inc. Quote, ISIS Quote

Isis Pharmaceuticals, Inc. (NQ:ISIS) Delayed: 22.76 -0.32 (1.39%)	Trade Now!
Previous Close	$23.08	52 Week High	$24.04
Open	$23.03	52 Week Low	$7.56
Day High	$23.03	P/E	N/A
Day Low	$22.45	EPS	$-0.42
Volume	347,269

Jun 18, 2013 07:00 AM Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Jun 13, 2013 07:58 PM Form 4 ISIS PHARMACEUTICALS For: Jun 11 Filed by: Monia Brett P
Jun 10, 2013 07:00 AM Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
Jun 6, 2013 08:15 AM Isis Pharma (ISIS) Receives $6M from AstraZeneca (AZN) in Research Collaboration
Jun 6, 2013 07:00 AM Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
Jun 5, 2013 07:00 AM Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Jun 4, 2013 07:58 AM Needham & Company Upbeat on ISIS Pharmaceuticals (ISIS) Following ASCO
Jun 3, 2013 02:02 PM Isis Pharma (ISIS) Presents Data from ISIS-STAT3Rx Phase 1 in Cancer
Jun 3, 2013 02:00 PM Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer
Jun 3, 2013 07:02 AM Isis Pharma (ISIS) Will Receive $10M Milestone from ISIS-ARRx Development (AZN)

May 7, 2013 04:01 PM Isis Pharmaceuticals, Inc. (ISIS) Reports In-Line Q1 Loss of 2c/Share
Feb 28, 2013 08:38 AM Isis Pharmaceuticals, Inc. (ISIS) Tops Q4 EPS by 20c
Jan 30, 2013 06:37 AM Isis (ISIS), Genzyme (SNY) Receive FDA Approval for KYNAMRO NDA
Jan 29, 2013 06:08 PM FDA Approves Isis Pharmaceuticals (ISIS) drug KYNAMRO
Nov 6, 2012 08:34 AM Isis Pharmaceuticals, Inc. (ISIS) Posts Q3 Loss of 37c/Share; Revs Light
Oct 18, 2012 05:33 PM FDA votes to Approve KYNAMRO for Homozygous Familial Hypercholesterolemia (SNY) (ISIS)
Aug 6, 2012 12:56 PM Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c
Feb 29, 2012 07:03 AM Isis Pharmaceuticals, Inc. (ISIS) Posts Mixed Q4 Results
Feb 29, 2012 07:03 AM Isis Pharmaceuticals, Inc. (ISIS) Posts Wider than Expected Q4 Loss
Nov 7, 2011 04:52 PM Isis Pharmaceuticals, Inc. (ISIS) Posts Q3 Loss of $0.27, Sales Miss Expectations

Jun 6, 2013 08:15 AM Isis Pharma (ISIS) Receives $6M from AstraZeneca (AZN) in Research Collaboration
Jun 4, 2013 07:58 AM Needham & Company Upbeat on ISIS Pharmaceuticals (ISIS) Following ASCO
Jun 3, 2013 02:02 PM Isis Pharma (ISIS) Presents Data from ISIS-STAT3Rx Phase 1 in Cancer
Jun 3, 2013 07:02 AM Isis Pharma (ISIS) Will Receive $10M Milestone from ISIS-ARRx Development (AZN)
May 8, 2013 09:31 AM StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
May 7, 2013 06:08 PM Streetinsider.com After-Hours Movers 05/07: (WBMD) (WFM) (EA) Higher; (OCLR) (SYNC) (VCLK) Lower (more...)
May 7, 2013 06:06 PM Isis Pharmaceuticals (ISIS) to Offer 9M Shares
May 7, 2013 04:01 PM Isis Pharmaceuticals, Inc. (ISIS) Reports In-Line Q1 Loss of 2c/Share
May 6, 2013 07:10 AM Isis Pharma (ISIS) Commences ISIS-STAT3Rx Phase 1b/2a in Advanced HCC
Apr 8, 2013 09:23 AM Isis Pharma (ISIS) to resume trading at 9:45am ET

Jun 18, 2013 07:00 AM Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Jun 10, 2013 07:00 AM Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
Jun 6, 2013 07:00 AM Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
Jun 5, 2013 07:00 AM Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Jun 3, 2013 02:00 PM Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer
Jun 3, 2013 07:00 AM Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer
May 31, 2013 04:30 PM Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares
May 23, 2013 07:00 AM Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
May 13, 2013 07:00 AM Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
May 9, 2013 04:34 PM Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec

Jun 13, 2013 07:58 PM Form 4 ISIS PHARMACEUTICALS For: Jun 11 Filed by: Monia Brett P
May 31, 2013 07:15 PM Form 4 ISIS PHARMACEUTICALS For: May 30 Filed by: MUTO FREDERICK T
May 9, 2013 04:30 PM Form 8-K ISIS PHARMACEUTICALS For: May 08
May 7, 2013 04:16 PM Form 8-K ISIS PHARMACEUTICALS For: May 07
May 7, 2013 03:58 PM Form 10-Q ISIS PHARMACEUTICALS For: Mar 31
May 2, 2013 07:48 PM Form 4 ISIS PHARMACEUTICALS For: Apr 30 Filed by: BENNETT C FRANK
Apr 26, 2013 07:06 PM Form 4 ISIS PHARMACEUTICALS For: Apr 24 Filed by: PARSHALL B LYNNE
Apr 26, 2013 07:02 PM Form 4 ISIS PHARMACEUTICALS For: Apr 24 Filed by: HOUGEN ELIZABETH L
Apr 26, 2013 07:02 PM Form 4 ISIS PHARMACEUTICALS For: Apr 24 Filed by: CROOKE STANLEY T
Apr 23, 2013 09:05 PM Form 4 ISIS PHARMACEUTICALS For: Apr 19 Filed by: O'NEIL PATRICK R.

Entities mentioned with ISIS